This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignee: University of California. Active years: 2019-2021.
Company Filing History:
Years Active: 2019-2021
Title: Innovations by Inventor Xiang Yin
Introduction
Xiang Yin is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of medical science, particularly in the development of compounds aimed at treating various health conditions. With a total of 4 patents to his name, his work continues to impact the medical community.
Latest Patents
Xiang Yin's latest patents include innovative methods for addressing critical health issues. One of his patents focuses on glutarate compounds for treating ischemia-reperfusion injuries. This patent discloses methods for preventing, inhibiting, reducing, or treating ischemia and reperfusion injury to tissues using glutarate compounds such as α-ketoglutarate. Another significant patent involves ketobutyrate compounds and compositions for treating age-related symptoms and diseases. This patent outlines methods for treating, inhibiting, or reducing aging in subjects, as well as addressing age-related symptoms and diseases, ultimately aiming to increase the lifespan of individuals through the administration of ketobutyrate compounds.
Career Highlights
Xiang Yin is affiliated with the University of California, where he conducts research and develops his innovative ideas. His work has garnered attention for its potential to improve health outcomes and enhance the quality of life for many individuals.
Collaborations
Xiang has collaborated with several talented individuals in his field, including Mansoureh Eghbali and Jingyuan Li. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Xiang Yin's contributions to medical science through his innovative patents demonstrate his commitment to improving health and addressing critical issues. His work continues to inspire and pave the way for future advancements in the field.
